[Destruction of the articular cartilage in osteoarthritis].

Masashi Okubo, Yasunori Okada

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Osteoarthritis (OA) is the most common joint disease characterized by destruction of articular cartilage induced primarily by mechanical stresses to joints. Destruction of the articular cartilage in OA is caused by combination of increased degradation of ECM (extracellular matrix) , decreased production of ECM and chondrocyte death. Members of the MMP (matrix metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene families are considered to play a key role in the degradation of cartilage.

Original languageEnglish
Pages (from-to)1705-1713
Number of pages9
JournalClinical calcium
Volume23
Issue number12
Publication statusPublished - 2013 Dec

Fingerprint

Articular Cartilage
Osteoarthritis
Extracellular Matrix
Thrombospondins
Disintegrins
Mechanical Stress
Joint Diseases
Metalloproteases
Chondrocytes
Matrix Metalloproteinases
Cartilage
Joints
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Okubo, M., & Okada, Y. (2013). [Destruction of the articular cartilage in osteoarthritis]. Clinical calcium, 23(12), 1705-1713.

[Destruction of the articular cartilage in osteoarthritis]. / Okubo, Masashi; Okada, Yasunori.

In: Clinical calcium, Vol. 23, No. 12, 12.2013, p. 1705-1713.

Research output: Contribution to journalArticle

Okubo, M & Okada, Y 2013, '[Destruction of the articular cartilage in osteoarthritis].', Clinical calcium, vol. 23, no. 12, pp. 1705-1713.
Okubo, Masashi ; Okada, Yasunori. / [Destruction of the articular cartilage in osteoarthritis]. In: Clinical calcium. 2013 ; Vol. 23, No. 12. pp. 1705-1713.
@article{eab5c2fd28a14485a1f711f0ec891f8d,
title = "[Destruction of the articular cartilage in osteoarthritis].",
abstract = "Osteoarthritis (OA) is the most common joint disease characterized by destruction of articular cartilage induced primarily by mechanical stresses to joints. Destruction of the articular cartilage in OA is caused by combination of increased degradation of ECM (extracellular matrix) , decreased production of ECM and chondrocyte death. Members of the MMP (matrix metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene families are considered to play a key role in the degradation of cartilage.",
author = "Masashi Okubo and Yasunori Okada",
year = "2013",
month = "12",
language = "English",
volume = "23",
pages = "1705--1713",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "12",

}

TY - JOUR

T1 - [Destruction of the articular cartilage in osteoarthritis].

AU - Okubo, Masashi

AU - Okada, Yasunori

PY - 2013/12

Y1 - 2013/12

N2 - Osteoarthritis (OA) is the most common joint disease characterized by destruction of articular cartilage induced primarily by mechanical stresses to joints. Destruction of the articular cartilage in OA is caused by combination of increased degradation of ECM (extracellular matrix) , decreased production of ECM and chondrocyte death. Members of the MMP (matrix metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene families are considered to play a key role in the degradation of cartilage.

AB - Osteoarthritis (OA) is the most common joint disease characterized by destruction of articular cartilage induced primarily by mechanical stresses to joints. Destruction of the articular cartilage in OA is caused by combination of increased degradation of ECM (extracellular matrix) , decreased production of ECM and chondrocyte death. Members of the MMP (matrix metalloproteinase) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene families are considered to play a key role in the degradation of cartilage.

UR - http://www.scopus.com/inward/record.url?scp=84895852523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895852523&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 1705

EP - 1713

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 12

ER -